Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
Is MEDIFAST (MED) a Great Value Stock Right Now?
10:46am, Wednesday, 15'th Jun 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
5 Top-Ranked Stocks Empowered by DuPont Analysis
09:15am, Wednesday, 15'th Jun 2022
Have more faith in DuPont analysis than simple ROE calculation and bet on these five stocks.
Can Medifast rise above the $190 resistance?
01:21pm, Monday, 13'th Jun 2022
Medifast Inc (NYSE:MED) is a consumer defensive value stock. Investors would consider buying and holding for the bear market.
10 Best Dividend Stocks to Buy Now
11:23am, Saturday, 11'th Jun 2022
These top dividend stocks are attractive at these levels and lower, and they add excellent diversity to a long-term investing portfolio.
3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)
02:18pm, Wednesday, 08'th Jun 2022
Medifast (MED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Should Value Investors Buy MEDIFAST (MED) Stock?
11:17am, Monday, 30'th May 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Medifast: Growth And Value At A Reasonable Price
10:36am, Tuesday, 17'th May 2022
Positive Q1 results that confirm our thesis. Unique business proposition, self-financed with a virtuous circle.
5 High Earnings Yield Value Picks Amid Market Jitters
09:02am, Monday, 16'th May 2022
Value investing should be one of the most effective investment approaches now. IMO, CF, CC, MED and APA are some high earnings yield value stocks to tide over market mayhem.
Are Investors Undervaluing MEDIFAST (MED) Right Now?
11:17am, Friday, 13'th May 2022
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
3 Reasons Why Medifast (MED) Is a Great Growth Stock
02:18pm, Tuesday, 10'th May 2022
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Medifast (MED) Tops Q1 Earnings & Sales Estimates, Raises View
12:47pm, Wednesday, 04'th May 2022
Medifast's (MED) first-quarter 2022 results reflect increased earnings and revenues owing to continued strength in OPTAVIA. Management raises sales and earnings view for 2022.
Medifast, Inc.'s (MED) CEO Dan Chard on Q1 2022 Results - Earnings Call Transcript
10:10pm, Monday, 02'nd May 2022
Gaia, Inc. (GAIA) Q1 2022 Earnings Conference Call May 2, 2022 4:30 PM ET Company Participants Dan Chard - Chairman and CEO Jim Maloney - Chief Financial Officer Conference Call Participants Chris Nea
Medifast (MED) Q1 Earnings and Revenues Top Estimates
08:18pm, Monday, 02'nd May 2022
Medifast (MED) delivered earnings and revenue surprises of 0.84% and 0.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
2 Ugly Ducklings To Consider For Your Dividend Growth Portfolio
12:21pm, Friday, 29'th Apr 2022
Primerica and Medifast are two companies that can be punished because of unusual business models. Both Primerica and Medifast have excellent fundamentals and have shown the ability to grow the dividen
Things to Note as Medifast (MED) Lines Up for Q1 Earnings
09:06am, Friday, 29'th Apr 2022
Medifast's (MED) first-quarter results are likely to reflect gains from the OPTAVIA lifestyle solution and coaching support system, whereas high costs are a concern.
